Drug
Nb003
Nb003: highest development phase Phase 2/3, developed by Ningbo Newbay Technology Development Co., Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Ningbo Newbay Technology Development Co., Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| NB003 NCT07379047 | Phase 2/3 | GIST - Gastrointestinal Stromal Tumor |
Latest
No recent events.
Follow Nb003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.